BrainStorm and Octane Biotech Announce Success in Cocoon Application Development Based on Customized Bioreactor for NurOwn® Stem Cells

By: via Benzinga
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.